{
    "title": "U.S. FDA declines to review Soligenix's cancer drug; shares sink",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11749323/U-S-FDA-declines-review-Soligenixs-cancer-drug.html",
    "date": "2023-02-14",
    "keywords": [
        "drug",
        "application",
        "treatment",
        "company",
        "fda",
        "cancer",
        "hybryte",
        "tcell",
        "food",
        "administration",
        "approval",
        "developer",
        "tuesday",
        "trading",
        "review",
        "agency",
        "path",
        "forward",
        "ointment",
        "type",
        "blood",
        "skin",
        "companys",
        "therapy",
        "soligenix",
        "half",
        "marketing",
        "december",
        "merger",
        "acquisition",
        "cash",
        "sept",
        "latestage",
        "study",
        "reduction",
        "placebo",
        "group",
        "cycle",
        "cure",
        "lymphoma",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}